Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences
Dr. Jane S. Lebkowski, Ph.D., has been Scientific Advisor of Asterias Biotherapeutics, Inc. since November 30, 2017. Dr. Lebkowski serves as an Advisor of BEAT BioTherapeutics Corp. Dr. Lebkowski served as the Chief Scientific Officer of Asterias Biotherapeutics, Inc. from 2009 to November 30, 2017. Dr. Lebkowski served as President of Research and Development at Asterias Biotherapeutics, Inc. from March 2013 until June 27, 2017. She served as the Chief Scientific Officer and Senior Vice President of Geron Corporation from May 2011 to December 31, 2011. She served as Chief Scientific Officer of Cell Therapy at Geron Corporation from February 2009 to May 2011 and served as its Senior Vice President of Cell Therapy from January 2004 to May 2011. Dr. Lebkowski served as Senior Vice President of Regenerative Medicine of Geron Corporation since January 2004 and served as its Chief Scientific Officer of Regenerative Medicine since 2009. Dr. Lebkowski served as Vice President of Regenerative Medicine of Geron Corporation from August 1999 to January 2004. From April 1998 to August 1999, Dr. Lebkowski served as a Senior Director of Cell and Gene Therapies at Geron. Dr. Lebkowski served as Vice President of Research and Development at Applied Immune Sciences from 1986 to 1995. In 1995, Applied Immune Sciences was acquired by Rhone-Poulenc Rorer, at which time Dr. Lebkowski served as a Vice President of Discovery & Product Development. Dr. Lebkowski holds a B.S. in Chemistry and Biology from Syracuse University and a Ph.D. from Princeton University.